© Drug Hunter Inc. 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > BMS-986202
<< Back to December
oral JH2-binding Tyk2 inhibitor
Ph. I in psoriasis complete
backup candidate to BMS-986165 for psoriasis
J. Med. Chem., Dec. 28, 2020
Bristol-Myers Squibb, Princeton, NJ
Bristol Myers Squibb (BMS) oral JH2-domain binding Tyk2 kinase inhibitor
Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.